The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.
Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship
Open accessAbstract
The incidence and prevalence of metabolic and musculoskeletal diseases are increasing. Type 2 diabetes mellitus (T2DM) is characterized by insulin resistance, inflammation, advanced glycation end-product accumulation and increased oxidative stress. These characteristics can negatively affect various aspects of muscle health, including muscle mass, strength, quality and function through impairments in protein metabolism, vascular and mitochondrial dysfunction, and cell death. Sarcopenia is a term used to describe the age-related loss in skeletal muscle mass and function and has been implicated as both a cause and consequence of T2DM. Sarcopenia may contribute to the development and progression of T2DM through altered glucose disposal due to low muscle mass, and also increased localized inflammation, which can arise through inter- and intramuscular adipose tissue accumulation. Lifestyle modifications are important for improving and maintaining mobility and metabolic health in individuals with T2DM and sarcopenia. However, evidence for the most effective and feasible exercise and dietary interventions in this population is lacking. In this review, we discuss the current literature highlighting the bidirectional relationship between T2DM and sarcopenia, highlight current research gaps and treatments, and provide recommendations for future research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Engin Üstün, Y. (n.d.) · DergiPark (Istanbul University) · Cited by 170,090
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 1×
“In the US Diabetes Prevention Program which included 3,234 nondiabetic adults, a lifestyle modification program (lowcalorie, diet-induced weight loss of 7% of initial body weight and ≥150 min moderate-intensity physical activity per week) resulted in 58% reduced incidence of T2DM over three years, which was significan…”
BackgroundRepertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
Sarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
Cho, N. H., Shaw, J. E., Karuranga, S., Huang, Y., da Rocha Fernandes, J. D., Ohlrogge, A. W., & Malanda, B. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.02.023 · Cited by 7,283
Trumbo, P., Schlicker, S., Yates, A. A., & Poos, M. (2002) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(02)90346-9 · Cited by 5,993
Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia
Chen, L.-K., Liu, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Bahyah, K. S., Chou, M.-Y., Chen, L.-Y., Hsu, P.-S., Krairit, O., et al. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.11.025 · Cited by 4,051
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Cited by
Type 2 diabetes mellitus in older adults: clinical considerations and management
Bellary, S., Kyrou, I., Brown, J. E., & Bailey, C. J. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00512-2 · Cited by 639
Emerging Targets in Type 2 Diabetes and Diabetic Complications
Demir, S., Nawroth, P. P., Herzig, S., & Ekim Üstünel, B. (2021) · Advanced Science · doi:10.1002/advs.202100275 · Cited by 525
A Narrative Review on Sarcopenia in Type 2 Diabetes Mellitus: Prevalence and Associated Factors
Izzo, A., Massimino, E., Riccardi, G., & Della Pepa, G. (2021) · Nutrients · doi:10.3390/nu13010183 · Cited by 418
Christensen, S., Robinson, K., Thomas, S., & Williams, D. R. (2024) · Obesity Pillars · doi:10.1016/j.obpill.2024.100121 · Cited by 108
“A possible contributor to muscle loss in patients with T2DM is insulin resistance, which impairs glucose uptake by muscle and can reduce its mass, strength, quality, and function [38].”
BackgroundAdverse muscle composition predicts all‐cause mortality in the UK Biobank imaging study
Linge, J., Petersson, M., Forsgren, M. F., Sanyal, A. J., & Dahlqvist Leinhard, O. (2021) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12834 · Cited by 108
Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective
Prokopidis, K., Cervo, M. M., Gandham, A., & Scott, D. (2020) · Nutrients · doi:10.3390/nu12082285 · Cited by 99
Self-citationEffects of Antidiabetic Drugs on Muscle Mass in Type 2 Diabetes Mellitus
Ida, S., Kaneko, R., Imataka, K., Okubo, K., Shirakura, Y., Azuma, K., Fujiwara, R., & Murata, K. (2021) · Current Diabetes Reviews · doi:10.2174/1573399816666200705210006 · Cited by 85
Volpe, S., Lisco, G., Fanelli, M., Racaniello, D., Colaianni, V., Lavarra, V., Triggiani, D., Crudele, L., Triggiani, V., Sabbà, C., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1240263 · Cited by 73
Sbrignadello, S., Göbl, C., & Tura, A. (2022) · Nutrients · doi:10.3390/nu14091864 · Cited by 68
Higher Risk of Sarcopenia in Older Adults with Type 2 Diabetes: NHANES 1999–2018
Dai, S., Shu, D., Meng, F., Chen, Y., Wang, J., Liu, X., Xiao, X., Guo, W., & Chen, F. (2023) · Obesity Facts · doi:10.1159/000530241 · Cited by 63
Ferrari, U., Then, C., Rottenkolber, M., Selte, C., Seissler, J., Conzade, R., Linkohr, B., Peters, A., Drey, M., & Thorand, B. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01523-7 · Cited by 52
Manickam, R., Tur, J., Badole, S. L., Chapalamadugu, K. C., Sinha, P., Wang, Z., Russ, D. W., Brotto, M., & Tipparaju, S. M. (2022) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12887 · Cited by 50
Adverse muscle composition is a significant risk factor for all-cause mortality in NAFLD
Linge, J., Nasr, P., Sanyal, A. J., Dahlqvist Leinhard, O., & Ekstedt, M. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2022.100663 · Cited by 42
Sylivris, A., Mesinovic, J., Scott, D., & Jansons, P. (2022) · Obesity Reviews · doi:10.1111/obr.13442 · Cited by 39
Self-citationFanelli, S. M., Kelly, O. J., Krok-Schoen, J. L., & Taylor, C. A. (2021) · Nutrients · doi:10.3390/nu13082582 · Cited by 29
Lifestyle Medicine for Obesity in the Era of Highly Effective Anti-Obesity Treatment
Sannidhi, D., Abeles, R., Andrew, W., Bonnet, J. P., Vitale, K., Niranjan, V., Gulati, M., Pauly, K., Moran, R., Alexander, L., et al. (2025) · Nutrients · doi:10.3390/nu17142382 · Cited by 29
“- Preserves lean mass [136,143,158,194,195].”
Physical activity and exercise in the management of type 2 diabetes: where to start?
Harrington, D., & Henson, J. (2021) · Practical Diabetes · doi:10.1002/pdi.2361 · Cited by 29
Kaur, I., Das, S., Chandel, S., & Chandel, S. (2025) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2025.103185 · Cited by 13
Kramer, P. A., Coen, P. M., Cawthon, P. M., Distefano, G., Cummings, S. R., Goodpaster, B. H., Hepple, R. T., Kritchevsky, S. B., Shankland, E. G., Marcinek, D. J., et al. (2024) · The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glad283 · Cited by 8
Abuduwaili, H., Kamoshita, K., Ishii, K.-A., Takahashi, K., Abuduyimiti, T., Qifang, L., Isobe, Y., Goto, H., Nakano, Y., Takeshita, Y., et al. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00270.2022 · Cited by 7
Metadata
- Authors
- Mesinovic, J., Zengin, A., De Courten, B., Ebeling, P. R., & Scott, D.
- Venue
- Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
- Publisher
- Informa UK Limited
- Published
- 2019-07
- Volume
- Volume 12
- Pages
- 1057-1072
- ISSN
- 1178-7007 (ISSN-L)
- OpenAlex
- W2954950466
- Cited by
- 553
- References
- 171
- FWCI
- 30.43
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.